A 55-year-old with HFrEF (EF 25%) remains NYHA III despite GDMT. No hyperkalemia. What add-on therapy is recommended to improve symptoms and outcomes ...

Question

A 55-year-old with HFrEF (EF 25%) remains NYHA III despite GDMT. No hyperkalemia. What add-on therapy is recommended to improve symptoms and outcomes specifically in self-identified Black patients?

Accepted Answer

Hydralazine plus isosorbide dinitrate

Answer

Ivabradine

Answer

Digoxin

Answer

Vericiguat

Answer

Amlodipine

us-abim MCQ (SBA): Heart Failure (HFrEF)

A 55-year-old with HFrEF (EF 25%) remains NYHA III despite GDMT. No hyperkalemia. What add-on therapy is recommended to improve symptoms and outcomes specifically in self-identified Black patients?